search
Back to results

Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment

Primary Purpose

Infertility

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Medication Management Software
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Infertility

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women undergoing IVF cycle (planning egg retrieval) at University of Michigan, for any indication (infertility, fertility preservation, or genetic disorder planning preimplantation genetic screening or diagnosis)
  • English as primary language
  • Owns a smartphone
  • Owns a non-smartphone device with access to the internet at home (tablet, laptop computer, or desktop computer)
  • Has internet access at home

Exclusion Criteria:

  • Non-English speaker as primary language
  • Previous participant in same study
  • Not undergoing IVF fertility treatment
  • Does not own a smartphone
  • Does not own a tablet, laptop computer, or desktop computer
  • Does not have internet access at home

Sites / Locations

  • Center for Reproductive Medicine, University of Michigan
  • Northville Health Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental Software Group

Control Group

Arm Description

Subjects in the experimental group will be provided with free access to the medication management software online, which will be able to be accessed on the SmartPhone/SmartDevice and home tablet(s) or computer(s) of their choice, through any browser. They will also be provided with links to the surveys to be filled out in the REDCap secure web application throughout the study.

Subjects in the control group will receive standard of care, and will receive emails with links to the surveys to be filled out in the REDCap secure web application throughout the study.

Outcomes

Primary Outcome Measures

Documented Medication Errors
Common medication errors such as wrong dose, missed dose, or running out of medication, as captured through the software and/or reported by the patient to the clinical team caring for them during their IVF cycle.

Secondary Outcome Measures

Number of Phone and Patient Portal Messages to Infertility Nurses
Number of phone and patient portal (electronic health record) messages to infertility nurses from patients using the software as compared to those using standard pencil/paper or homegrown methods to track medication inventory.
Quantity of Medication Waste
Amount of medication patient has left at the end of the IVF cycle, as an indication of medication tracking errors.
Stress Level
Change in stress levels as measured by CART (Concerns of Women Undergoing Assisted Reproductive Technologies) survey.
Anxiety Level
Change in state anxiety score as measured by Spielberger's State-Trait Anxiety Inventory survey.
Quality of Life
Change in quality of life assessment as measured by FertiQoL (Fertility Patient Quality of Life) questionnaire.

Full Information

First Posted
December 19, 2017
Last Updated
December 14, 2020
Sponsor
University of Michigan
search

1. Study Identification

Unique Protocol Identification Number
NCT03383848
Brief Title
Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment
Official Title
Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
January 10, 2018 (Actual)
Primary Completion Date
October 31, 2020 (Actual)
Study Completion Date
October 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will evaluate if an electronic medication management software solution can improve outcomes for patients undergoing in vitro fertilization (IVF) treatment. Participants will be randomized equally into two groups: half will use the management software, while the other half will act as a control group.
Detailed Description
In the United States, individuals suffering from infertility pursued approximately 190,000 cycles of in vitro fertilization (IVF) in 2014, with approximately 1.5 million cycles performed internationally. Without insurance coverage, each cycle can cost between $15,000 and $25,000 for medications and procedures. The goal of an IVF cycle is a healthy baby, but to achieve this goal, patients and their partners are asked to manage administration and inventory of between 6 and 12 medications with doses and routes that can change daily. Due to the complexity of the treatment and the fact that the medications are expensive and ordered by patients incrementally to reduce large amounts of waste, medication errors (wrong dose; missed dose; running out of medication) are common (3-15% of patients). The current standard is that patients manage this process of medication inventory, administration, and refills on their own with their own systems, using paper calendars provided by a clinic (which are immediately inaccurate once the cycle starts), paper-and-pencil lists, electronic lists, or generic medication-tracking applications, combined with verbal and written reminders from their clinic. Not having the right medication at the right time is the most critical error, and with the current methods, the patient often does not realize this fact while there is sufficient time to rectify the inventory problem, and the clinic has no way to catch at-risk patients proactively. For these patients, this error can mean a sub-optimal response with a lower chance of pregnancy that particular month (as low as 0%, depending on the error). Of the patients undergoing IVF with perfect adherence, only about 50% achieve the goal of a healthy baby. For the remainder, there will always be the concern that perhaps they could have had a different outcome, and for those with a medication error, they will never know whether the outcome could have been different if that error had not occurred. This study will determine if patients using medication management software will have lower numbers of documented medication errors (as captured through the software and/or reported by the patient to the clinical team caring for them during their IVF cycle) compared to patients who use standard paper/pencil or home-grown methods to track their medication inventory.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
164 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental Software Group
Arm Type
Experimental
Arm Description
Subjects in the experimental group will be provided with free access to the medication management software online, which will be able to be accessed on the SmartPhone/SmartDevice and home tablet(s) or computer(s) of their choice, through any browser. They will also be provided with links to the surveys to be filled out in the REDCap secure web application throughout the study.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Subjects in the control group will receive standard of care, and will receive emails with links to the surveys to be filled out in the REDCap secure web application throughout the study.
Intervention Type
Device
Intervention Name(s)
Medication Management Software
Intervention Description
The OnTrack Medication Management Software allows patients to track the amount of fertility medication they have at home. When they check off their "to do" list of medications, it decrements the amount they have at home. It allows them to see when they will run out of medication depending on their current doses (which can change daily). Daily use of the software will be 5-10 minutes daily for approximately 21 days.
Primary Outcome Measure Information:
Title
Documented Medication Errors
Description
Common medication errors such as wrong dose, missed dose, or running out of medication, as captured through the software and/or reported by the patient to the clinical team caring for them during their IVF cycle.
Time Frame
End of treatment cycle, between day 9 and day 15
Secondary Outcome Measure Information:
Title
Number of Phone and Patient Portal Messages to Infertility Nurses
Description
Number of phone and patient portal (electronic health record) messages to infertility nurses from patients using the software as compared to those using standard pencil/paper or homegrown methods to track medication inventory.
Time Frame
End of treatment cycle, between day 9 and day 15
Title
Quantity of Medication Waste
Description
Amount of medication patient has left at the end of the IVF cycle, as an indication of medication tracking errors.
Time Frame
End of treatment cycle, between day 9 and day 15
Title
Stress Level
Description
Change in stress levels as measured by CART (Concerns of Women Undergoing Assisted Reproductive Technologies) survey.
Time Frame
Baseline, between stimulation days 6 and 8, and on the day prior to egg retrieval (between day 9 and day 15 of treatment cycle)
Title
Anxiety Level
Description
Change in state anxiety score as measured by Spielberger's State-Trait Anxiety Inventory survey.
Time Frame
Baseline, between stimulation days 6 and 8, and on the day prior to egg retrieval (between day 9 and day 15 of treatment cycle)
Title
Quality of Life
Description
Change in quality of life assessment as measured by FertiQoL (Fertility Patient Quality of Life) questionnaire.
Time Frame
Baseline, between stimulation days 6 and 8, and on the day prior to egg retrieval (between day 9 and day 15 of treatment cycle)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women undergoing IVF cycle (planning egg retrieval) at University of Michigan, for any indication (infertility, fertility preservation, or genetic disorder planning preimplantation genetic screening or diagnosis) English as primary language Owns a smartphone Owns a non-smartphone device with access to the internet at home (tablet, laptop computer, or desktop computer) Has internet access at home Exclusion Criteria: Non-English speaker as primary language Previous participant in same study Not undergoing IVF fertility treatment Does not own a smartphone Does not own a tablet, laptop computer, or desktop computer Does not have internet access at home
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Lanham, MD
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Center for Reproductive Medicine, University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48108
Country
United States
Facility Name
Northville Health Center
City
Northville
State/Province
Michigan
ZIP/Postal Code
48168
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34016436
Citation
Martin CE, Lanham M, Almgren-Bell A, Marsh C, Omurtag K. A randomized controlled trial to evaluate the use of a web-based application to manage medications during in vitro fertilization. Fertil Steril. 2021 Sep;116(3):793-800. doi: 10.1016/j.fertnstert.2021.04.022. Epub 2021 May 18.
Results Reference
derived

Learn more about this trial

Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment

We'll reach out to this number within 24 hrs